Article

Allergan announces Horizon Grant recipients

Irvine, CA-Allergan Inc. has announced the recipients of its first Allergan Horizon Grant Program awards. The company will contribute $1 million over 2 years to academic medical institutions to support fellows conducting clinical research in the diagnosis or pharmacologic treatment of glaucoma and corneal and retinal diseases.

Irvine, CA-Allergan Inc. has announced the recipients of its first Allergan Horizon Grant Program awards. The company will contribute $1 million over 2 years to academic medical institutions to support fellows conducting clinical research in the diagnosis or pharmacologic treatment of glaucoma and corneal and retinal diseases.

Ten grants were awarded to 13 ophthalmology programs. Three programs will share the $40,000 between two therapeutic areas.

Grants for cornea research were awarded to the Cullen Eye Institute, Baylor College of Medicine, Houston; the Duke University Eye Center, Durham, NC; the Jules Stein Eye Institute (JSEI), University of California, Los Angeles; and the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore.

Grants for glaucoma research went to the Duke University Medical Center, Durham, NC; the University of California, Davis; JSEI; The New York Eye & Ear Infirmary; and the University of California, San Diego.

Grants for retinal disease research were awarded to the Wilmer Eye Institute; Columbia University, New York; the Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami; and the Vanderbilt Eye Institute, Vanderbilt University, Nashville.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.